Quote | Pyxis Oncology Inc. (NASDAQ:PYXS)
Last: | $4.34 |
---|---|
Change Percent: | 0.67% |
Open: | $4.48 |
Close: | $4.34 |
High: | $4.55 |
Low: | $4.31 |
Volume: | 228,997 |
Last Trade Date Time: | 05/10/2024 03:00:00 am |
News | Pyxis Oncology Inc. (NASDAQ:PYXS)
BOSTON, May 09, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, announced today that Lara S. Sullivan, M.D., President and Chief Executive Officer, will participate in a...
2024-04-12 17:05:37 ET Gainers: Applied Optoelectronics ( AAOI ) +5% . Eliem Therapeutics ( ELYM ) +4% . Infinera Corporation ( INFN ) +4% . Harrow ( HROW ) +4% . Health Catalyst ( HCAT ) +4% . Losers: Eagle Pharmaceutica...
Message Board Posts | Pyxis Oncology Inc. (NASDAQ:PYXS)
Subject | By | Source | When |
---|---|---|---|
I did, nice P&D | TheFinalCD | investorshub | 04/10/2023 12:15:10 AM |
Wouldn't touch it until we see if that | SpaceTimeRift777 | investorshub | 04/05/2023 12:40:01 PM |
Perfect example of dilution,in other words a classic | spencer22 | investorshub | 04/04/2023 11:19:03 AM |
7). https://finviz.com/quote.ashx?t=$PYXS&p=d$10.75 PYX | 0210 | investorshub | 03/31/2023 9:23:02 PM |
buyin' dips $4.00 - $4.10. https://ih.advfn.com/stock-market/NASDAQ/pyxis-oncology-$PYXS/tr | 0210 | investorshub | 03/31/2023 8:42:02 PM |
News, Short Squeeze, Breakout and More Instantly...
Pyxis Oncology Inc. Company Name:
PYXS Stock Symbol:
NASDAQ Market:
BOSTON, May 09, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (NASDAQ:PYXS), a clinical stage company focused on developing next generation ther...
BOSTON, May 09, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, announced today that Lara S. Sullivan, M.D., President and Chief Executive Officer, will participate in a...
Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the J.P. Morgan Re...